Cargando…

Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?

BACKGROUND: Differences in adherence may represent drug properties (e.g. dosing interval) or patient experiences while on treatment. Adherence to direct oral anticoagulants (DOACs) in nonvalvular atrial fibrillation (NVAF) is important to maintain effectiveness over the course of treatment. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Phuong N., Brown, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423818/ https://www.ncbi.nlm.nih.gov/pubmed/30890131 http://dx.doi.org/10.1186/s12872-019-1033-3

Ejemplares similares

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
por: Hernandez, Inmaculada, et al.
Publicado: (2019)

Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation
por: Seelig, J, et al.
Publicado: (2022)

Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
por: Ko, Darae, et al.
Publicado: (2022)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
por: Lip, Gregory Y. H., et al.
Publicado: (2018)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
por: Yong, Celina M., et al.
Publicado: (2020)

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2022)

Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
por: Kim, Kyu, et al.
Publicado: (2018)

Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis
por: Rodríguez-Bernal, Clara L, et al.
Publicado: (2018)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data
por: Bean, Daniel M., et al.
Publicado: (2019)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
por: El Kadri, Moutaz, et al.
Publicado: (2021)

Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation
por: Jankowska-Polańska, Beata, et al.
Publicado: (2016)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter?
por: Martin, Anne-Céline, et al.
Publicado: (2020)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
por: Obayashi, Yuki, et al.
Publicado: (2021)

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
por: Cools, Frank, et al.
Publicado: (2021)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
por: Apenteng, Patricia N, et al.
Publicado: (2018)

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015)

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
por: Contractor, Tahmeed, et al.
Publicado: (2011)

An Automated Clinical Alert System for Newly-Diagnosed Atrial Fibrillation
por: Cook, David A., et al.
Publicado: (2015)

Stroke Severity and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation
por: Watanabe, Kotaro, et al.
Publicado: (2021)

Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation
por: Benzimra, Michaël, et al.
Publicado: (2018)

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2019)

Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis
por: Teixeira, Ana, et al.
Publicado: (2021)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
por: Song, Ting, et al.
Publicado: (2021)

Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation
por: Yang, Lanting, et al.
Publicado: (2021)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants
por: Gabet, Amélie, et al.
Publicado: (2021)

Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2018)

Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
por: Pham, Phuong, et al.
Publicado: (2020)

Direct oral anti-Xa anticoagulants versus warfarin in newly diagnosed atrial fibrillation and CKD: the Korean National Health Insurance Data
por: Kee, Youn Kyung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1248ll55ug27158j8204a5r5ts